TALLAHASSEE, Fla. — Global Green Inc. announces that it has received the final report on the model Efficacy Study conducted on the company’s patented vaccine, Salmogenics, to be used to protect poultry from salmonella bacteria.
This study, conducted by AHPharma, an independent food safety and animal health research firm, is an important step towards receiving USDA approval for Salmogenics.
The study was performed using 3,036 chickens, specifically broilers. Those chickens injected in ovo (in the egg before the chick is hatched) with Salmogenics showed a significant reduction in salmonella bacteria.
The study reports that the “Salmogenics Vaccine appears to. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
